The role of hepatokines in NAFLD

N Stefan, F Schick, AL Birkenfeld, HU Häring, MF White - Cell metabolism, 2023 - cell.com
Non-alcoholic fatty liver disease (NAFLD) is not only a consequence of insulin resistance,
but it is also an important cause of insulin resistance and major non-communicable diseases …

The impact of insulin resistance on the kidney and vasculature

F Artunc, E Schleicher, C Weigert, A Fritsche… - Nature Reviews …, 2016 - nature.com
Insulin resistance is a systemic disorder that affects many organs and insulin-regulated
pathways. The disorder is characterized by a reduced action of insulin despite increased …

Inflammation–nature's way to efficiently respond to all types of challenges: implications for understanding and managing “the epidemic” of chronic diseases

JM Bennett, G Reeves, GE Billman… - Frontiers in …, 2018 - frontiersin.org
Siloed or singular system approach to disease management is common practice,
developing out of traditional medical school education. Textbooks of medicine describe a …

The role of hepatokines in metabolism

N Stefan, HU Häring - Nature Reviews Endocrinology, 2013 - nature.com
The liver is known to be involved in the natural history of the ongoing epidemics of type 2
diabetes mellitus and cardiovascular disease. In particular, the liver has a role in increased …

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

NF Schwenzer, F Springer, C Schraml, N Stefan… - Journal of …, 2009 - Elsevier
Hepatic steatosis is the most prevalent liver disorder in the developed world. It is closely
associated with features of metabolic syndrome, especially insulin resistance and obesity …

Metabolic adaptation in obesity and type II diabetes: myokines, adipokines and hepatokines

KJ Oh, DS Lee, WK Kim, BS Han, SC Lee… - International journal of …, 2016 - mdpi.com
Obesity and type II diabetes are characterized by insulin resistance in peripheral tissues. A
high caloric intake combined with a sedentary lifestyle is the leading cause of these …

Causes and metabolic consequences of fatty liver

N Stefan, K Kantartzis, HU Häring - Endocrine reviews, 2008 - academic.oup.com
Type 2 diabetes and cardiovascular disease represent a serious threat to the health of the
population worldwide. Although overall adiposity and particularly visceral adiposity are …

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study

BD Parker, LJ Schurgers, VM Brandenburg… - Annals of internal …, 2010 - acpjournals.org
Background: Fibroblast growth factor 23 (FGF23), uncarboxylated matrix Gla protein
(ucMGP), and fetuin-A are regulators of mineral metabolism and inhibitors of vascular …

Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK

JH Ix, K Sharma - Journal of the American Society of Nephrology, 2010 - journals.lww.com
Obesity is a risk factor for chronic kidney disease (CKD) and nonalcoholic fatty liver disease
(NAFLD). Recent studies identify mechanisms common to both diseases linked through an …

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease

VWS Wong, GLH Wong, GWK Yip, AOS Lo… - Gut, 2011 - gut.bmj.com
Objective Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic
syndrome and is associated with cardiovascular risk. The aim of this study was to determine …